Diovan (Valsartan)



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 87.5%
Blood Pressure 12.5%
Blood Pressure Increased 36.4%
Blood Pressure Diastolic Increased 4.5%
Blood Pressure Inadequately Controlled 4.5%
Drug Ineffective 4.5%
Fear 4.5%
Gait Disturbance 4.5%
Headache 4.5%
Hypertension 4.5%
Nausea 4.5%
Neck Pain 4.5%
Renal Failure 4.5%
Stress 4.5%
Vein Disorder 4.5%
Vertigo 4.5%
Wheezing 4.5%
Secondary
Hypertension 25.0%
Product Used For Unknown Indication 12.5%
Blood Pressure Abnormal 6.3%
Diabetes Mellitus 6.3%
Thyroid Disorder 6.3%
Atrial Fibrillation 3.1%
Blood Cholesterol Abnormal 3.1%
Blood Pressure High 3.1%
Cataplexy 3.1%
Dementia Alzheimer's Type 3.1%
Diabetic Neuropathy 3.1%
Faeces Hard 3.1%
High Cholesterol 3.1%
Multiple Sclerosis 3.1%
Myelodysplastic Syndrome 3.1%
Parkinson's Disease 3.1%
Renal Cancer 3.1%
Tinnitus 3.1%
Vulvovaginal Pain 3.1%
Dizziness 11.1%
Drug Hypersensitivity 11.1%
Agranulocytosis 5.6%
Gastritis 5.6%
Hypertension 5.6%
Ileus 5.6%
Influenza Like Illness 5.6%
Musculoskeletal Stiffness 5.6%
Off Label Use 5.6%
Palpitations 5.6%
Pneumonia 5.6%
Throat Irritation 5.6%
Tongue Injury 5.6%
Urticaria 5.6%
Vertigo 5.6%
Weight Decreased 5.6%
Concomitant
Hypertension 26.6%
Product Used For Unknown Indication 7.7%
Diabetes Mellitus 7.3%
Plasma Cell Myeloma 6.9%
Blood Cholesterol Increased 5.8%
Type 2 Diabetes Mellitus 5.1%
Multiple Sclerosis 4.4%
Osteoporosis 4.4%
Chronic Myeloid Leukaemia 3.6%
Pain 3.3%
Prophylaxis 3.3%
Blood Pressure High 2.9%
Depression 2.9%
Nephrogenic Anaemia 2.9%
Anxiety 2.6%
Atrial Fibrillation 2.2%
Hepatitis C 2.2%
Prostate Cancer Metastatic 2.2%
Actinic Keratosis 1.8%
Anticoagulant Therapy 1.8%
Vomiting 12.1%
Pancreatitis 8.8%
Weight Decreased 6.6%
Weight Increased 6.6%
Drug Ineffective 5.5%
Pain 5.5%
White Blood Cell Count Decreased 5.5%
Nausea 4.4%
Rash 4.4%
Renal Failure Chronic 4.4%
Stress Fracture 4.4%
Urinary Retention 4.4%
Urinary Tract Infection 4.4%
Insomnia 3.3%
Off Label Use 3.3%
Palpitations 3.3%
Pancreatitis Acute 3.3%
Platelet Count Decreased 3.3%
Renal Impairment 3.3%
Skin Exfoliation 3.3%
Interacting
Fibromyalgia 25.0%
Hypertension 25.0%
Neuralgia 25.0%
Asthma 12.5%
Diabetes Mellitus 12.5%
Weight Increased 100.0%